Theralase Technologies Inc. filed its Annual on Apr 26, 2023 for the period ending Dec 31, 2022. In this report its auditor, Richter LLP, gave an unqualified opinion expressing doubt that the company can continue as a going concern.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.19 CAD | -2.56% | +2.70% | +8.57% |
06-06 | Theralase Technologies Inc. Successfully Destroys Lung Cancer | CI |
06-04 | Theralase® Technology Effective in Virus Inactivation | CI |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+8.57% | 33.91M | |
-2.51% | 840M | |
-30.04% | 225M | |
-30.50% | 79.99M | |
+14.99% | 60.36M |
- Stock Market
- Equities
- TLT Stock
- News Theralase Technologies Inc.
- Theralase Technologies Inc. Auditor Raises 'Going Concern' Doubt